ArticleCancer immunology, immunotherapy : CII2021

Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy.

Qingsheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.